Chapter 065


Enacted 06/20/07





     Introduced By: Senators Walaska, McCaffrey, and Alves

     Date Introduced: February 13, 2007


It is enacted by the General Assembly as follows:


     SECTION 1. Section 5-19.1-2 of the General Laws in Chapter 5-19.1 entitled

"Pharmacies" is hereby amended to read as follows:


     5-19.1-2. Definitions. -- (a) "Board" means the Rhode Island board of pharmacy.

      (b) "Change of ownership" means:

      (1) In the case of a pharmacy, manufacturer, or wholesaler which is a partnership any

change which results in a new partner acquiring a controlling interest in the partnership;

      (2) In the case of a pharmacy, manufacturer or wholesaler which is a sole proprietorship,

the transfer of the title and property to another person;

      (3) In the case of a pharmacy, manufacturer, or wholesaler which is a corporation:

      (i) A sale, lease exchange, or other disposition of all or substantially all of the property

and assets of the corporation; or

      (ii) A merger of the corporation into another corporation; or

      (iii) The consolidation of two (2) or more corporations, resulting in the creation of a new

corporation; or

      (iv) In the case of a pharmacy, manufacturer, or wholesaler which is a business

corporation, any transfer of corporate stock which results in a new person acquiring a controlling

interest in the corporation; or

      (v) In the case of a pharmacy, manufacturer, or wholesaler which is a nonbusiness

corporation, any change in membership which results in a new person acquiring a controlling

vote in the corporation.

      (c) "Compounding" shall be the act of combining two (2) or more ingredients as a result

of a practitioner's prescription or medication order occurring in the course of professional practice

based upon the individual needs of a patient and a relationship between the practitioner, patient,

and pharmacist. Compounding does not mean the routine preparation, mixing or assembling of

drug products that are essentially copies of a commercially available product. Compounding shall

only occur in the pharmacy where the drug or device is dispensed to the patient or caregiver and

includes the preparation of drugs or devices in anticipation of prescription orders based upon

routine, regularly observed prescribing patterns.

      (d) "Controlled substance" means a drug or substance, or an immediate precursor of such

drug or substance, so designated under or pursuant to the provisions of chapter 28 of title 21.

      (e) "Deliver" or "delivery" means the actual, constructive, or attempted transfer from one

person to another of a drug or device, whether or not there is an agency relationship.

      (f) "Device" means instruments, apparatus, and contrivances, including their

components, parts, and accessories, intended (1) for use in the diagnosis, cure, mitigation,

treatment, or prevention of disease in man or other animals, or (2) to affect the structure or any

function of the body of man or other animals.

      (g) "Director" means the director of the Rhode Island state department of health.

      (h) "Dispense" means the interpretation of a prescription or order for a drug, biological,

or device and, pursuant to that prescription or order, the proper selection, measuring,

compounding, labeling, or packaging necessary to prepare that prescription or order for delivery

or administration.

      (i) "Distribute" means the delivery of a drug or device other than by administering or


      (j) "Drug" means:

      (1) Articles recognized in the official United States Pharmacopoeia or the official

homeopathic pharmacopoeia of the U.S.;

      (2) Substances intended for use in the diagnosis, cure, mitigation, treatment, or

prevention of disease in man or other animals;

      (3) Substances (other than food) intended to affect the structure or any function of the

body of man or other animals; or

      (4) Substances intended for use as a component of any substances specified in

subdivisions (1), (2), or (3) of this subsection and section 5-19-1(16), but not including devices or

their component parts or accessories.

      (k) "Equivalent and interchangeable" means having the same generic name, dosage form,

and labeled potency, meeting standards of the United States Pharmacopoeia or National

Formulary, or their successors, if applicable, and not found in violation of the requirements of the

United States Food and Drug Administration, or its successor agency, or the Rhode Island

department of health.

      (l) "Intern" means a graduate of an American Council on Pharmaceutical Education

(ACPE) accredited program of pharmacy, or a student who is enrolled in at least the first year of a

professional ACPE accredited program of pharmacy, or a graduate of a foreign college of

pharmacy who has obtained full certification from the FPGEC (Foreign Pharmacy Graduate

Equivalency Commission) administered by the National Association of Boards of Pharmacy.

      (m) "Legend drugs" means any drugs which are required by any applicable federal or

state law or regulation to be dispensed on prescription only or are restricted to use by practitioners


      (n) "Manufacture" means the production, preparation, propagation, compounding, or

processing of a drug or other substance or device or the packaging or repackaging.

      (o) "Nonlegend" or "nonprescription drugs" means any drugs which may be lawfully

sold without a prescription.

      (p) "Person" means an individual, corporation, government, subdivision or agency,

business trust, estate, trust, partnership or association, or any other legal entity.

      (q) "Pharmaceutical care" is the provision of drugs and other pharmaceutical services

intended to achieve outcomes related to cure or prevention of a disease, elimination or reduction

of a patient's symptoms, or arresting or slowing of a disease process. Pharmaceutical care

includes the judgment of a pharmacist in dispensing an equivalent and interchangeable drug or

device in response to a prescription, after appropriate communication with the prescriber and the


      (r) "Pharmacist-in-charge" means a pharmacist licensed in this state is designated by the

owner as the person responsible for the operation of a pharmacy in conformance with all laws and

regulations pertinent to the practice of pharmacy and who is personally in full and actual charge

of such pharmacy and personnel.

      (s) "Pharmacy" means that portion or part of a premise where prescriptions are

compounded and dispensed, including that portion utilized for the storage of prescription or

legend drugs.

      (t) "Pharmacy technician" means an individual who meets minimum qualifications

established by the board, which are less than those established by this chapter as necessary for

licensing as a pharmacist; and works under the direction and supervision of a licensed pharmacist.

      (u) "Practice of pharmacy" means the interpretation, evaluation, and implementation of

medical orders; the dispensing of prescription drug orders; participation in drug and device

selection; the compounding of prescription drugs; drug regimen reviews and drug or drug related

research; the administration of adult immunizations pursuant to a valid prescription or physician

approved protocol and in accordance with regulations, to include training requirements as

promulgated by the department of health; provision of patient counseling and the provision of

those acts or services necessary to provide pharmaceutical care; and/or the responsibility for the

supervision for compounding and labeling of drugs and devices (except labeling by a

manufacturer, repackager, or distributor of non-prescription drugs and commercially packaged

legend drugs and devices), proper and safe storage of drugs and devices, and maintenance of

proper records for them. Nothing in this definition shall be construed to limit or otherwise affect

the scope of practice of any other profession.

      (v) "Practitioner" means a physician, dentist, veterinarian, nurse or other person duly

authorized by law in the state in which they practice to prescribe drugs.

      (w) "Preceptor" means a pharmacist registered to engage in the practice of pharmacy in

this state, who has the responsibility for training interns.

      (x) "Prescription" means an order for drugs or devices issued by the practitioner duly

authorized by law in the state in which he practices to prescribe drugs or devices in the course of

his or her professional practice for a legitimate medical purpose.

      (y) "Wholesaler" shall mean a person who buys drugs or devices for resale and

distribution to corporations, individuals, or entities other than consumers.


     SECTION 2. This act shall take effect on October 1, 2007.



LC01907/SUB A/2